APA (7th ed.) Citation

Rajala, H. L. M., Anttila, V., Haapio, M., Keränen, M. A. I., Wartiovaara-Kautto, U., & Räty, R. Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases. Wiley.

Chicago Style (17th ed.) Citation

Rajala, Hanna L. M., Veli-Jukka Anttila, Mikko Haapio, Mikko A. I. Keränen, Ulla Wartiovaara-Kautto, and Riikka Räty. Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases. Wiley.

MLA (9th ed.) Citation

Rajala, Hanna L. M., et al. Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases. Wiley.